Minimally Invasive Distal Pancreatectomy
Conditions
Keywords
Benign or borderline pathology (non-pancreatic cancer), laparoscopy, registrar, postoperative outcomes, pancreatectomy, surgery, pancreas
Brief summary
This study aimed to determine whether registrar involvement in minimally invasive distal pancreatectomy (MIDP) was associated with adverse outcomes.
Detailed description
From January 2009 to March 2020, data of all consecutive patients requiring distal pancreatectomy in our public tertiary hospital were prospectively collected and retrospectively analyzed. Registrars were progressively involved for MIDP since 2009 and their experience was: \< 5 open pancreatic resections, \< 5 MIDP and at least 30 advanced minimally invasive gastrointestinal resections. Outcome of patients who underwent either distal pancreatectomy by the consultant or registrars were compared. Our primary outcome was the conversion rate. The secondary outcomes were 90-days postoperative outcomes including CR-POPF defined and classified according to the 2016 ISGPF definition.
Interventions
Minimally invasive distal pancreatectomy
Sponsors
University Hospital, Montpellier
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
\- Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology between 2009-2020
Exclusion criteria
* open distal pancreatectomy * minimally invasive distal pancreatectomy for pancreatic cancer * 20 first consecutive patients operated on by the consultant (learning curve)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| open conversion rate | 1 day | Necessity to swith from minimally invasive approach to open approach during laparoscopy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| lenght of hospital stay | 90 days postoperative | lenght of hospital stay |
| readmission rate | 90 days postoperative | readmission rate |
| reoperation rate | 90 days postoperative | reoperation rate |
| clinically relevant postoperative fistula | 90 days postoperative | clinically relevant postoperative fistula (2016 ISGPF definition) |
| postoperative complications | 90 days postoperative | postoperative complications |
| Intraoperative bloodloss | 1 day | Intraoperative bloodloss |
| Intraoperative transfusion | 1 day | Intraoperative transfusion |
| severe complications Clavien Dindo>3 | 90 days postoperative | severe complications Clavien Dindo\>3 |
| Duration of surgery | 1 day | Duration of surgery |
Countries
France
Outcome results
None listed